These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 21239513)
1. Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. Marfella R; Ferraraccio F; Rizzo MR; Portoghese M; Barbieri M; Basilio C; Nersita R; Siniscalchi LI; Sasso FC; Ambrosino I; Siniscalchi M; Maresca L; Sardu C; Amato G; Paolisso G; Carella C J Clin Endocrinol Metab; 2011 Apr; 96(4):1015-20. PubMed ID: 21239513 [TBL] [Abstract][Full Text] [Related]
2. Proteasome activity as a target of hormone replacement therapy-dependent plaque stabilization in postmenopausal women. Marfella R; Di Filippo C; Portoghese M; Ferraraccio F; Crescenzi B; Siniscalchi M; Barbieri M; Bologna C; Rizzo MR; Rossi F; D'Amico M; Paolisso G Hypertension; 2008 Apr; 51(4):1135-41. PubMed ID: 18259030 [TBL] [Abstract][Full Text] [Related]
3. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity. Marfella R; Siniscalchi M; Portoghese M; Di Filippo C; Ferraraccio F; Schiattarella C; Crescenzi B; Sangiuolo P; Ferraro G; Siciliano S; Cinone F; Mazzarella G; Martis S; Verza M; Coppola L; Rossi F; D'Amico M; Paolisso G Hypertension; 2007 Apr; 49(4):784-91. PubMed ID: 17309948 [TBL] [Abstract][Full Text] [Related]
4. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. Marfella R; D'Amico M; Di Filippo C; Baldi A; Siniscalchi M; Sasso FC; Portoghese M; Carbonara O; Crescenzi B; Sangiuolo P; Nicoletti GF; Rossiello R; Ferraraccio F; Cacciapuoti F; Verza M; Coppola L; Rossi F; Paolisso G J Am Coll Cardiol; 2006 Jun; 47(12):2444-55. PubMed ID: 16781372 [TBL] [Abstract][Full Text] [Related]
5. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. Marfella R; D'Amico M; Esposito K; Baldi A; Di Filippo C; Siniscalchi M; Sasso FC; Portoghese M; Cirillo F; Cacciapuoti F; Carbonara O; Crescenzi B; Baldi F; Ceriello A; Nicoletti GF; D'Andrea F; Verza M; Coppola L; Rossi F; Giugliano D Diabetes; 2006 Mar; 55(3):622-32. PubMed ID: 16505224 [TBL] [Abstract][Full Text] [Related]
6. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy. Hellings WE; Pasterkamp G; Verhoeven BA; De Kleijn DP; De Vries JP; Seldenrijk KA; van den Broek T; Moll FL J Vasc Surg; 2007 Feb; 45(2):289-96; discussion 296-7. PubMed ID: 17264005 [TBL] [Abstract][Full Text] [Related]
7. Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization. Profumo E; Buttari B; Tosti ME; Tagliani A; Capoano R; D'Amati G; Businaro R; Salvati B; Riganò R J Cardiovasc Surg (Torino); 2013 Jun; 54(3):349-57. PubMed ID: 22669090 [TBL] [Abstract][Full Text] [Related]
8. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808 [TBL] [Abstract][Full Text] [Related]
9. Markers of instability in high-risk carotid plaques are reduced by statins. Kunte H; Amberger N; Busch MA; Rückert RI; Meiners S; Harms L J Vasc Surg; 2008 Mar; 47(3):513-22. PubMed ID: 18295103 [TBL] [Abstract][Full Text] [Related]
10. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636 [TBL] [Abstract][Full Text] [Related]
11. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability. Sigala F; Kotsinas A; Savari P; Filis K; Markantonis S; Iliodromitis EK; Gorgoulis VG; Andreadou I J Vasc Surg; 2010 Sep; 52(3):704-13. PubMed ID: 20573470 [TBL] [Abstract][Full Text] [Related]
12. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. Alvarez B; Ruiz C; Chacón P; Alvarez-Sabin J; Matas M J Vasc Surg; 2004 Sep; 40(3):469-75. PubMed ID: 15337875 [TBL] [Abstract][Full Text] [Related]
13. Association between 5-lipoxygenase expression and plaque instability in humans. Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1665-70. PubMed ID: 15933245 [TBL] [Abstract][Full Text] [Related]
14. Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment. Balestrieri ML; Rizzo MR; Barbieri M; Paolisso P; D'Onofrio N; Giovane A; Siniscalchi M; Minicucci F; Sardu C; D'Andrea D; Mauro C; Ferraraccio F; Servillo L; Chirico F; Caiazzo P; Paolisso G; Marfella R Diabetes; 2015 Apr; 64(4):1395-406. PubMed ID: 25325735 [TBL] [Abstract][Full Text] [Related]
15. Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients. Grufman H; Schiopu A; Edsfeldt A; Björkbacka H; Nitulescu M; Nilsson M; Persson A; Nilsson J; Gonçalves I Atherosclerosis; 2014 Nov; 237(1):177-82. PubMed ID: 25240113 [TBL] [Abstract][Full Text] [Related]
16. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. van Oostrom O; Velema E; Schoneveld AH; de Vries JP; de Bruin P; Seldenrijk CA; de Kleijn DP; Busser E; Moll FL; Verheijen JH; Virmani R; Pasterkamp G Cardiovasc Pathol; 2005; 14(3):126-34. PubMed ID: 15914297 [TBL] [Abstract][Full Text] [Related]
17. Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism. Adrees M; Gibney J; El-Saeity N; Boran G Clin Endocrinol (Oxf); 2009 Aug; 71(2):298-303. PubMed ID: 19094068 [TBL] [Abstract][Full Text] [Related]
18. Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. Shakoor SK; Aldibbiat A; Ingoe LE; Campbell SC; Sibal L; Shaw J; Home PD; Razvi S; Weaver JU J Clin Endocrinol Metab; 2010 Jan; 95(1):319-22. PubMed ID: 19897678 [TBL] [Abstract][Full Text] [Related]
19. Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis. Kunte H; Kunte G; Busch MA; Weichert W; Rückert RI; Harms L Atherosclerosis; 2010 Aug; 211(2):456-60. PubMed ID: 20427044 [TBL] [Abstract][Full Text] [Related]
20. Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss. Bernardi LA; Cohen RN; Stephenson MD Fertil Steril; 2013 Nov; 100(5):1326-31. PubMed ID: 23954357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]